Trial
NCT05070247
A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors
Phase ITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Takeda
Collaborators
—
Condition
Pancreatic Cancer
Intervention
TAK-500
Why stopped
Clinical Futility of TAK 500 met. No further development with this compound
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-01-22